Oxyphenisatin acetate

DB14627ApprovedWithdrawnSmall molecule

Oxyphenisatin acetate is the pro-drug of oxyphenisatin (3,3-bis(4-hydroxyphenyl)-1H-indol-2-one). The FDA withdrew its approval for the use of oxyphenisatin acetate due to safety reasons.

Formula / weight: C₂₄H₁₉NO₅ · 401.418 g/mol (avg)
Also known as: Oxyphenisatin diacetate · Oxyphenisatine acetate

Resolves to

Compound

UNIIU0Y1YAL65XCAS115-33-3ChEMBLCHEMBL1402684ChEBI135638

Structure

InChIKeyPHPUXYRXPHEJDF-UHFFFAOYSA-NSMILESCC(=O)OC1=CC=C(C=C1)C1(C(=O)NC2=CC=CC=C12)C1=CC=C(OC(C)=O)C=C1

What you can answer from here — as of March 06, 2025

402Drug interactionsStructured to mechanism, not free text

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Oxyphenisatin acetate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account